Matthew Adlam

861 total citations
11 papers, 738 citations indexed

About

Matthew Adlam is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Matthew Adlam has authored 11 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Matthew Adlam's work include T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Matthew Adlam is often cited by papers focused on T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Matthew Adlam collaborates with scholars based in United States, Czechia and Austria. Matthew Adlam's co-authors include Gerald Siu, Niharika Nath, Sheng Wang, Srikumar Chellappan, Maureen A. Morrow, Cesar A. Perez, David D. Duncan, Sisi Zhang, Joshua D. Rabinowitz and Thomas P. Lynch and has published in prestigious journals such as Blood, Immunity and Molecular Cell.

In The Last Decade

Matthew Adlam

11 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Adlam United States 10 509 218 129 96 65 11 738
Graham Craggs United Kingdom 7 468 0.9× 130 0.6× 126 1.0× 114 1.2× 39 0.6× 8 650
Bei Morrison United States 11 399 0.8× 125 0.6× 141 1.1× 70 0.7× 176 2.7× 12 581
Kyoichiro Higashi Japan 11 399 0.8× 115 0.5× 110 0.9× 63 0.7× 64 1.0× 15 628
Mark E. Drotar United Kingdom 9 401 0.8× 157 0.7× 187 1.4× 75 0.8× 28 0.4× 15 753
Ross J. Resnick United States 13 759 1.5× 162 0.7× 125 1.0× 186 1.9× 120 1.8× 22 889
Joshua J. Oaks United States 9 710 1.4× 90 0.4× 115 0.9× 72 0.8× 129 2.0× 19 876
Vanessa Ott United States 13 342 0.7× 498 2.3× 155 1.2× 73 0.8× 237 3.6× 17 1.1k
Jaime Symowicz United States 8 375 0.7× 94 0.4× 218 1.7× 138 1.4× 87 1.3× 8 603
Maja Milanovic Germany 12 403 0.8× 171 0.8× 124 1.0× 116 1.2× 32 0.5× 21 646
Thijs J. Hagenbeek Netherlands 8 475 0.9× 354 1.6× 182 1.4× 79 0.8× 44 0.7× 11 772

Countries citing papers authored by Matthew Adlam

Since Specialization
Citations

This map shows the geographic impact of Matthew Adlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Adlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Adlam more than expected).

Fields of papers citing papers by Matthew Adlam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Adlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Adlam. The network helps show where Matthew Adlam may publish in the future.

Co-authorship network of co-authors of Matthew Adlam

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Adlam. A scholar is included among the top collaborators of Matthew Adlam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Adlam. Matthew Adlam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Moloughney, Joseph G., Peter K. Kim, Sisi Zhang, et al.. (2016). mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1. Molecular Cell. 63(5). 811–826. 109 indexed citations
2.
Xu, Han, Michele McElvain, Mike Fiorino, et al.. (2013). Predictability of Peripheral Lymphocyte Reduction of Novel S1P1 Agonists by In Vitro GPCR Signaling Profile. SLAS DISCOVERY. 18(9). 997–1007. 3 indexed citations
3.
Bürli, Roland W., Han Xu, Xiaoming Zou, et al.. (2006). Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 16(14). 3713–3718. 103 indexed citations
4.
Ayuso‐Sacido, Ángel, Hailan Zhang, Stuart T. Fraser, et al.. (2006). Acceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse Mix-like homeodomain transcription factor. Blood. 107(8). 3122–3130. 35 indexed citations
5.
Schett, Georg, Marina Stolina, Brad Bolon, et al.. (2005). Analysis of the kinetics of osteoclastogenesis in arthritic rats. Arthritis & Rheumatism. 52(10). 3192–3201. 51 indexed citations
6.
Adlam, Matthew & Gerald Siu. (2003). Hierarchical Interactions Control CD4 Gene Expression during Thymocyte Development. Immunity. 18(2). 173–184. 40 indexed citations
7.
Donlin, Laura T., et al.. (2002). Defective Thymocyte Maturation by Transgenic Expression of a Truncated Form of the T Lymphocyte Adapter Molecule and Fyn Substrate, Sin. The Journal of Immunology. 169(12). 6900–6909. 10 indexed citations
8.
Wang, Sheng, Niharika Nath, Matthew Adlam, & Srikumar Chellappan. (1999). Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene. 18(23). 3501–3510. 197 indexed citations
9.
Morrow, Maureen A., et al.. (1999). Overexpression of the Helix–Loop–Helix protein Id2 blocks T cell development at multiple stages. Molecular Immunology. 36(8). 491–503. 115 indexed citations
10.
Adlam, Matthew. (1997). Positive selection induces CD4 promoter and enhancer function. International Immunology. 9(6). 877–887. 34 indexed citations
11.
Duncan, David D., Matthew Adlam, & Gerald Siu. (1996). Asymmetric Redundancy in CD4 Silencer Function. Immunity. 4(3). 301–311. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026